Inhibrx Biosciences (INBX) Q1 2026 Earnings

19MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-2.84
-2.46
-2.09
-1.72

Details

Expected EPS
-2.08
Actual EPS
-2.11
Surprise EPS
-0.03
Surprise Percent
+1.44%

Description

Inhibrx Biosciences (INBX) has reported earnings of -2.11 per share for Q1 2026.

0 Comments

Share your thoughts